In 1996, California became the first state to legalize medical marijuana, paving the way for nationwide reform. In the 28 ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...

Arrowhead Pharmaceuticals is a biotechnology company focused on developing RNA interference (RNAi) therapeutics. Their proprietary platform, Targeted RNAi Molecule (TRiM™), allows them to target and ...

The DVLA advises you should tell them if you develop a 'notifiable' medical condition or disability, or if a condition has ...